NYSE$ARMK
Aramark · Q4 2021 earnings
Q4 2021 earnings · · Investor relations
Briefing
Aramark's Q4 2021 results reflected progress across the business, with organic revenue reaching 87% of pre-COVID levels and record Net New Business performance achieved.
Aramark reported a 32% increase in revenue to $3.6 billion in Q4 2021, with organic revenue up 37%. Operating income increased by $226 million, and adjusted EPS increased by $0.56 to $0.21. The company achieved record Net New Business performance and improved profitability through increased sales volume and effective cost management.
- Revenue increased by 32%, with organic revenue up 37% year-over-year.
- Operating Income rose by $226 million, and Adjusted Operating Income (AOI) increased by $177 million compared to the previous year.
- EPS increased to $0.14, a $0.73 increase, while Adjusted EPS increased to $0.21, a $0.56 increase.
- The company's revenue reached 90% of pre-COVID levels, and organic revenue reached 87% of pre-COVID levels, driven by the FSS United States segment.
Headline financials
Revenue & EPS history
Aramark · Revenue · Quarterly
$3.55B
Forward guidance
Aramark expects continued recovery and strong performance in fiscal 2022, building on its Net New Business momentum. The company anticipates organic revenue growth between +23% and +27%, with revenue approaching pre-COVID levels by year-end. Adjusted Operating Income (AOI) margin is expected in the range of 5.0% to 5.5%, with the second half of the year reaching 6.0% to 6.5%. Free Cash Flow is projected between $300 million and $400 million, and annualized Net New Business is expected in the range of $550 million to $650 million.
Tailwinds
- Organic growth between +23% and +27% is expected.
- Revenue is anticipated to approach pre-COVID levels by year-end.
- Adjusted Operating Income (AOI) margin is projected in a range of 5.0% to 5.5%, with the second half of the year reaching 6.0% to 6.5%.
- Free Cash Flow is expected to be between $300 million and $400 million.
- Annualized Net New Business is projected in a range of $550 million to $650 million.
Headwinds
- The fiscal 2022 outlook reflects management's current assumptions regarding the continued impact of COVID-19 on Aramark and its clients.
- COVID-19 is expected to have a continued impact in fiscal 2022 of approximately $1.6 billion to $1.9 billion, or approximately 10% to 12% of pre-COVID revenue.
- New account start-ups in fiscal 2022 are expected to temporarily affect AOI margin due to lower margins in year one.
- The company has brought back operating and above unit costs in advance of full revenue recovery.
- The extent to which COVID-19 continues to impact business, operations, and financial results will depend on numerous evolving factors that are difficult to accurately predict.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q4 2021
+0.4%
Avg return
Earnings day
+1.5%
Avg return
5 days after
+3.4%
Avg return
30 days after
50%
27 / 54 earnings
Positive
+9.8%
Q2 2025
Best reaction
-9.0%
Q1 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2026 | +1.1% | +19.3% | +22.4% | |
| Q1 2026 | +5.6% | +0.5% | +3.1% | |
| Q4 2025 | -5.2% | -0.5% | -0.7% | |
| Q2 2025 | +9.8% | +12.2% | +16.2% | |
| Q1 2025 | -2.1% | -0.9% | -7.6% | |
| Q4 2024 | -2.8% | -4.5% | +4.2% | |
| Q3 2024 | +1.8% | +4.4% | +13.0% | |
| Q2 2024 | +0.8% | +5.3% | +3.4% | |
| Q1 2024 | -1.8% | +3.7% | +7.5% | |
| Q4 2023 | -5.2% | -2.8% | -3.3% | |
| Q3 2023 | +9.0% | +3.2% | -3.4% | |
| Q2 2023 | +7.2% | +8.9% | +19.0% | |
| Q1 2023 | -9.0% | -12.3% | -18.3% | |
| Q4 2022 | +4.2% | +4.6% | +7.4% | |
| Q3 2022 | +3.1% | +5.8% | +4.7% | |
| Q2 2022 | -4.4% | -1.8% | -1.5% | |
| Q1 2022 | +3.3% | -1.4% | -4.3% | |
| Q4 2021 | +0.3% | -3.9% | -12.2% | |
| Q3 2021 | +0.5% | +1.5% | -4.7% | |
| Q2 2021 | -3.5% | +3.9% | -0.3% | |
| Q1 2021 | -0.7% | -2.7% | +12.5% | |
| Q4 2020 | -3.3% | +1.0% | +7.9% | |
| Q3 2020 | +1.8% | +12.4% | +37.7% | |
| Q2 2020 | -7.0% | +2.1% | +10.5% | |
| Q1 2020 | -1.9% | -7.0% | -23.3% | |
| Q4 2019 | -0.4% | -1.9% | -0.5% | |
| Q3 2019 | +8.0% | +9.2% | +20.4% | |
| Q2 2019 | -2.6% | +0.0% | +12.4% | |
| Q1 2019 | -1.4% | -5.4% | -11.4% | |
| Q4 2018 | +2.4% | +6.6% | -5.4% | |
| Q3 2018 | +5.1% | +4.6% | +6.0% | |
| Q2 2018 | +1.1% | +2.6% | +6.1% | |
| Q1 2018 | -4.8% | -7.1% | -6.8% | |
| Q4 2017 | -7.0% | -4.7% | -2.0% | |
| Q3 2017 | +0.7% | -1.1% | +1.3% | |
| Q2 2017 | +2.9% | +1.5% | +9.1% | |
| Q1 2017 | +6.0% | +6.1% | +8.5% | |
| Q4 2016 | -8.7% | -6.6% | -0.6% | |
| Q3 2016 | +5.5% | +5.0% | +4.3% | |
| Q2 2016 | -3.2% | — | — | |
| Q1 2016 | -0.6% | — | — | |
| Q4 2015 | +9.2% | — | — | |
| Q3 2015 | -0.1% | — | — | |
| Q2 2015 | +1.6% | — | — | |
| Q1 2015 | -3.4% | — | — | |
| Q4 2012 | -1.5% | — | — | |
| Q4 2014 | +4.3% | — | — | |
| Q3 2013 | -0.3% | — | — | |
| Q3 2014 | -0.3% | — | — | |
| Q2 2013 | -2.0% | — | — | |
| Q2 2014 | -2.0% | — | — | |
| Q4 2013 | +3.4% | — | — | |
| Q1 2014 | +3.4% | — | — | |
| Q1 2013 | +3.4% | — | — | |
| Q3 2012 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro